Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
The phase 3 TRIUMPH-4 data confirmed: 12 mg retatrutide produced 23.7% weight loss, translating to an average of 60 pounds lost
Current evidence has not demonstrated significant liver toxicity associated with BPC-157
FSH, LH, and estradiol were all relatively low at baseline, reflecting the hypogonadal state of the participants
Hey guys
Lancet Oncol 16(7):763774 Gianni L et al (2014) Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort
The study enrolled 40 participants and is now complete, though the data have not yet been reported
US$ 27.40
US$ 25.30
US$ 25.69
US$ 26.02
US$ 28.05
US$ 25.84
US$ 23.18
US$ 29.04
US$ 22.17
US$ 26.56
